• 1

    McLaughlin CC, Wu XC, Jemal A. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103:10001007.

  • 2

    McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 2008;44:10391046.

    • Search Google Scholar
    • Export Citation
  • 3

    Mendenhall WM, Werning JW, Pfister DG. Treatment of head and neck cancer. In: DeVita VT Jr., Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2011:809877.

    • Search Google Scholar
    • Export Citation
  • 4

    Edge S, Byrd D, Compton C. AJCC Cancer Staging Manual, 7th ed. New York: Springer; 2010.

  • 5

    Colasanto JM, Prasad P, Nash MA. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) 2005;19:371379.

    • Search Google Scholar
    • Export Citation
  • 6

    Schnoll RA, Zhang B, Rue M. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 2003;21:355365.

    • Search Google Scholar
    • Export Citation
  • 7

    Gritz ER, Carr CR, Rapkin D. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261270.

    • Search Google Scholar
    • Export Citation
  • 8

    Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis 1970;23:455468.

  • 9

    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373383.

    • Search Google Scholar
    • Export Citation
  • 10

    Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593602.

  • 11

    Piccirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002;128:11721179.

    • Search Google Scholar
    • Export Citation
  • 12

    Piccirillo JF. Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma. Arch Otolaryngol Head Neck Surg 2000;126:10861088.

    • Search Google Scholar
    • Export Citation
  • 13

    Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001;23:566572.

  • 14

    Singh B, Bhaya M, Stern J. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997;107:14691475.

    • Search Google Scholar
    • Export Citation
  • 15

    Hall SF, Rochon PA, Streiner DL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:19881996.

  • 16

    Hall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 2000;22:317322.

    • Search Google Scholar
    • Export Citation
  • 17

    Ribeiro KC, Kowalski LP, Latorre MR. Impact of comorbidity, symptoms, and patients’ characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000;126:10791085.

    • Search Google Scholar
    • Export Citation
  • 18

    de Graeff A, de Leeuw JR, Ros WJ. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 2000;22:398407.

    • Search Google Scholar
    • Export Citation
  • 19

    Funk GF, Karnell LH, Whitehead S. Free tissue transfer versus pedicled flap cost in head and neck cancer. Otolaryngol Head Neck Surg 2002;127:205212.

    • Search Google Scholar
    • Export Citation
  • 20

    Farwell DG, Reilly DF, Weymuller EA. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg 2002;128:505511.

    • Search Google Scholar
    • Export Citation
  • 21

    Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 1974;27:387404.

    • Search Google Scholar
    • Export Citation
  • 22

    Bang D, Piccirillo J, Littenberg B. The Adult Comorbidity Evaluation-27 (ACE-27) test: a new comorbidity index for patients with cancer [abstract]. J Clin Oncol 2000;19(Suppl):Abstract 1701.

    • Search Google Scholar
    • Export Citation
  • 23

    Piccirillo JF, Costas I, Claybour P. The measurement of comorbidity by cancer registries. Journal of Registry Management 2003;30:814.

  • 24

    Patrick D, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press; 1993.

    • Search Google Scholar
    • Export Citation
  • 25

    Bachar G, Loh KS, O’Sullivan B. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 2008;30:13251331.

    • Search Google Scholar
    • Export Citation
  • 26

    Teppo H, Kervinen J, Koivunen P, Alho OP. Incidence and outcome of head and neck mucosal melanoma--a population-based survey from Northern Finland. Int J Circumpolar Health 2006;65:443447.

    • Search Google Scholar
    • Export Citation
  • 27

    Patel SG, Prasad ML, Escrig M. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002;24:247257.

  • 28

    Guo J, Si L, Kong Y. Phase II , open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol 2011;29:29042909.

    • Search Google Scholar
    • Export Citation
  • 29

    Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594611.

    • Search Google Scholar
    • Export Citation
  • 30

    Dauer EH, Lewis JE, Rohlinger AL. Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 2008;138:347352.

  • 31

    Meleti M, Leemans CR, de Bree R. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy. Head Neck 2008;30:15431551.

    • Search Google Scholar
    • Export Citation
  • 32

    Temam S, Mamelle G, Marandas P. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005;103:313319.

  • 33

    Trotti A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol 1993;9:246250.

    • Search Google Scholar
    • Export Citation
  • 34

    Ang KK, Peters LJ, Weber RS. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994;30:795798.

    • Search Google Scholar
    • Export Citation
  • 35

    Agrawal S, Kane JM III, Guadagnolo BA. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer 2009;115:58365844.

    • Search Google Scholar
    • Export Citation
  • 36

    Mendenhall WM, Amdur RJ, Hinerman RW. Head and neck mucosal melanoma. Am J Clin Oncol 2005;28:626630.

  • 37

    Burmeister B, Henderson M, Thompson J. Adjuvant radiotherapy improves regional (lymph node field) control in melanoma patients after lymphadenectomy: results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02) [abstract]. Int J Radiat Oncol Biol Phys 2009;75:S2.

    • Search Google Scholar
    • Export Citation
  • 38

    Benlyazid A, Thariat J, Temam S. Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg 2010;136:12191225.

    • Search Google Scholar
    • Export Citation
  • 39

    Moore ES, Martin H. Melanoma of the upper respiratory tract and oral cavity. Cancer 1955;8:11671176.

  • 40

    Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003;129:864868.

    • Search Google Scholar
    • Export Citation
  • 41

    Douglas CM, Malik T, Swindell R. Mucosal melanoma of the head and neck: radiotherapy or surgery? J Otolaryngol Head Neck Surg 2010;39:385392.

    • Search Google Scholar
    • Export Citation
  • 42

    Gilligan D, Slevin NJ. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991;64:11471150.

    • Search Google Scholar
    • Export Citation
  • 43

    Shibuya H, Takeda M, Matsumoto S. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys 1993;25:3539.

    • Search Google Scholar
    • Export Citation
  • 44

    Wada H, Nemoto K, Ogawa Y. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004;59:495500.

    • Search Google Scholar
    • Export Citation
  • 45

    Bonnen MD, Ballo MT, Myers JN. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004;100:383389.

    • Search Google Scholar
    • Export Citation
  • 46

    Ballo MT, Bonnen MD, Garden AS. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 2003;97:17891796.

  • 47

    Wu AJ, Gomez J, Zhung JE. Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 2010;33:281285.

  • 48

    Dirix P, Vanstraelen B, Jorissen M. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:9981004.

    • Search Google Scholar
    • Export Citation
  • 49

    Madani I, Bonte K, Vakaet L. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009;73:424432.

    • Search Google Scholar
    • Export Citation
  • 50

    Narasimhan K, Kucuk O, Lin HS. Sinonasal mucosal melanoma: a 13-year experience at a single institution. Skull Base 2009;19:255262.

  • 51

    Carvajal RD, Antonescu CR, Wolchok JD. KIT as a therapeutic target in metastatic melanoma. JAMA 2011;305:23272334.

  • 52

    Torres-Cabala CA, Wang WL, Trent J. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 2009;22:14461456.

    • Search Google Scholar
    • Export Citation
  • 53

    Harrison L, Sessions R, Hong W. Head and Neck Cancer: A Multidisciplinary Approach, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.

    • Search Google Scholar
    • Export Citation
  • 54

    Robbins KT, Shaha AR, Medina JE. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008;134:536538.

    • Search Google Scholar
    • Export Citation
  • 55

    Ferlito A, Rinaldo A, Silver CE. Elective and therapeutic selective neck dissection. Oral Oncol 2006;42:1425.

  • 56

    Sivanandan R, Kaplan MJ, Lee KJ. Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Arch Otolaryngol Head Neck Surg 2004;130:13691373.

    • Search Google Scholar
    • Export Citation
  • 57

    Robbins KT, Clayman G, Levine PA. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751758.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 553 387 16
PDF Downloads 179 113 8
EPUB Downloads 0 0 0